035 Experiences With Smo Antagonist Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

Journal of Investigative Dermatology- United Kingdom

doi 10.1016/j.jid.2017.07.131

Full Text

Abstract

Available in

Categories

Molecular Biology

Date

October 1, 2017

Authors

Publisher

Elsevier BV

Related search

Vismodegib and Orbital Excision for Treating Locally Advanced Basal Cell Carcinoma

International Medical Case Reports Journal

English

Vismodegib for Giant, Locally Advanced, Basal Cell Carcinoma and Its Complex Position in Clinical Practice

JAAD Case Reports

English

Granulation Tissue Masquerading as Basal Cell Carcinoma After Treatment With Vismodegib

JAAD Case Reports

English

Vismodegib for Periocular and Orbital Basal Cell Carcinoma

JAMA Ophthalmology

English

Basal Cell Cancer Treatment. Therapeutic Experience With Vismodegib Therapy

Medical Council

English

Lack of Response to Vismodegib in a Patient With Advanced Basal Cell Carcinoma: A Case Report

Journal of Clinical & Experimental Oncology

English

533 Pembrolizumab With or Without Vismodegib for Advanced Basal Cell Carcinoma: An Investigator-Initiated, Proof-Of-Concept Study

Journal of Investigative Dermatology

Molecular Biology

English

New Developments in the Treatment of Basal Cell Carcinoma: Update on Current and Emerging Treatment Options With a Focus on Vismodegib

OncoTargets and Therapy

English

The Current Status of Multimodality Treatment for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma

Asia-Pacific Journal of Clinical Oncology

English